Award recordCONTRACT

OTSUKA AMERICA PHARMACEUTICAL INC

PIID 36C26124N0298· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6505 · DRUGS AND BIOLOGICALS· FY2024· $24,411 net obligations· UEI QKABLBMA8FT9· MD

Description

DE-OB 612A40007 FOR CLOSEOUT.

Base award description: JYNARQUE

First action · last action
2023-12-07 · 2026-07-09
Transactions
3
First transaction's obligation
$24,411
Base + all options value (sum of deltas)
$24,411
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79720D0099
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$24,791$0Base award · 2023-12-07 · this action $24,411 · running total $24,411Modification P00001 · 2024-07-02 · this action $381 · running total $24,791Modification P00002 · 2026-07-09 · this action -$381 · running total $24,411
  • Base2023-12-07+$24,411= $24,411
  • Mod P000012024-07-02+$381= $24,791
  • Mod P000022026-07-09-$381= $24,411
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2023-12-07+$24,411$24,411JYNARQUE
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-07-02+$381$24,791JYNARQUE
Mod P00002· FUNDING ONLY ACTION2026-07-09−$381$24,411DE-OB 612A40007 FOR CLOSEOUT.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI QKABLBMA8FT9)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0783245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$20,378FY2026
36C24525N0988245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,243FY2025
36C24525N0987245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,168FY2025
36C24525N0901245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,168FY2025
36C24525N0789245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,168FY2025
36C24525N0683245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,168FY2025

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P1178OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026
36C26126P1102ENVIGO RMS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$74,586FY2026
36C26126P096110X GENOMICS, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$34,600FY2026
36C26126P0997SIERRA RADIOPHARMACY LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$247,204FY2026
36C26126P1008OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26124N0298_3600_36F79720D0099_3600 · retrieved 2026-09-26.